Clinical Trial Update: A Phase 1 Trial of ERX-315 in Participants With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 study of ERX-315 in patients with metastatic breast, ovarian, endometrial, liver, or pancreatic cancers is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Endometrial Cancer
• Liver Cancer
• Ovarian Cancer
• Pancreatic Cancer

Drugs mentioned

• ERX-315

Snippet

Sponsor: EtiraRx Australia Pty Ltd | Conditions: Advanced Solid Tumor, Metastatic Breast Cancer | Phase 1 | Status: RECRUITING